Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension

Medullary thyroid cancer (MTC) is a rare malignancy with a poor prognosis. First line therapy is surgery, which is the only curative method of the disease. However, in non-operable cases or with tumor progression and metastases, a systemic treatment is necessary. This form of cancer is often insensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Milling, Rikke Vilsbøll, Grimm, Daniela, Krüger, Marcus, Grosse, Jirka, Kopp, Sascha, Bauer, Johann, Infanger, Manfred, Wehland, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214082/
https://www.ncbi.nlm.nih.gov/pubmed/30347815
http://dx.doi.org/10.3390/ijms19103258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214082/
https://www.ncbi.nlm.nih.gov/pubmed/30347815
http://dx.doi.org/10.3390/ijms19103258

Ejemplares similares